Phase 1 evaluation of SF1126, a vascular targeted PI3K inhibitor, administered twice weekly IV
Four GIST patients have entered this Phase 1 trial of PI3K inhibitor SF1126.
LRG announces GIST Collaborative Tissue Bank initiative
Innovative project will allow GIST researchers worldwide to access GIST tissue linked to patient-provided clinical histories. For more information on the GIST Tissue bank read the official press release.
Community hospitals vs. cancer centers: should the patient be informed of the risks?
In a January New York Times article, “Should Patients Be Told of Better Care Elsewhere,” the author, Denise Grady, discusses a friend who was diagnosed with rectal cancer and needed surgery, radiation and chemotherapy. The friend consulted [...]
LRG Research Team holds second in-person meeting: new tissue banking initiative born
On March 6 and 7, the LRG Research Team met for the second in-person meeting at Brigham & Women’s Hospital in Boston, Mass. The Team had previously met in Portland, Oregon at Oregon Health & [...]
Cancer in the News: CMS broadens PET scan coverage, President Obama calls out cancer
The following article was reprinted from an email alert sent by LegisLink Action Center, a community education service of US Oncology. On September 16, the Centers for Medicare & Medicaid Services (CMS) broadened the scope [...]
Pat George: the man, the myth, the legend
Pat George, LRG member and volunteer is well-known in the community. Pat recently took it upon himself to help educate the local students
KIT signaling & new approaches for GIST therapy
KIT functions in several distinct cell types. Keep reading to learn about KIT signaling and new approaches for GIST Therapy.
Hereditary GIST explained
This article explains hereditary GIST. Familial cancer syndrome is a genetic condition that causes an increased risk for specific types of cancers. Familial cancer syndromes account for only five to ten percent of all [...]
FDA Approves Gleevec to Prevent Recurrence of Rare Gastrointestinal Cancer
Gleevec was approved by the Food and Drug Administration (FDA) to prevent Gastrointestinal Cancer(imatinib mesylate) for a new indication. This will keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor [...]
Fifth LRG Poker Tournament a Success
On November 20, 2008, the LRG held its Fifth Annual Poker Tournament at the Midtown Loft on Fifth Avenue in New York City. It is always a remarkable evening and has become a muchlooked- forward-to event for LRG staff and supporters.